This so call deal doesn't get done for at least another 6 months. In the mean time shorts will rule this stock. Should trade back under $60 before any movement back up.
Will cover when itu0027s trading under $60... Remember the deal is a least 6 months away from begin finalized, so shorts will rule this stock for the next 3 plus months.
You should thank God that the Ceo of BHI found a sucker to buy BHI for $78 At best BHI is worth $40 on it's own.
This deal is as good as dead. BHI well trade back under $50 with in a week or so. You should of sold this pos in pre-market. Makes a great short though. I see $40 with in a month
This way they can get BHI for $65 instead of the balloon price of $78. Always shorts deals like this, that's where the money is.....
Cowen downgraded Halliburton (NYSE: HAL) from Outperform to Market Perform.
Lower Hal share price goes, the lower the price offering for BHI. Not good if you are long.
Late Friday, a report from Bloomberg, citing people familiar with the matter, said that merger talks between the two sides have stalled over concerns regarding price and the potential sale of assets Not looking good!
Merger talks between Halliburton Co. (HAL) and Baker Hughes Inc. (BHI) stalled today following reports of the deal yesterday, with the companies still haggling over price and divestiture concerns, people with knowledge of the matter said.
Halliburton could make an unsolicited tender offer for Baker Hughes instead, and nominate a slate of directors to the target’s board, three of the people said, asking not to be identified discussing private information.
Since then, the two sides have become stuck on disagreements about the deal’s price and the billions of dollars in assets that would have to be sold for the deal to pass antitrust scrutiny, one of the people said. The two sides anticipate they may have to sell $7.5 billion to $10 billion in assets to address regulator concerns, said this person.
They may still be able to resume discussions and reach a deal, one of the people said. They May?
Roth Capital affirms Canadian Solar (Nasdaq: CSIQ) at Buy with a price target of $40 following Q3 results and guidance.
Analyst Philip Shen offered some overall thoughts on the company following results: “Despite a strong Q3 performance, weaker-than-expected margin guidance spooked investors. The market psychology for solar stocks has been challenging of late with any type of weakness serving as the lightning rod of attention. Given its capacity expansion plans, best-in-class brand, strong B/S, and rich downstream set of projects, we continue to believe that CSIQ is one of the best companies among its peers.”
Key takeaways from the report:
1. ASPs. Q4 ASPs could be as low as 63-64c/W due to mix and currency movements;
2. Q4 GMs may experience a few headwinds. Duty deposits could result in a 2% reduction in GMs; ASPs could decline due to geographic mix; Currency weakness may result in a 1-2% negative impact; Project sales may not be as margin rich as Q3; and
3. Quality balance sheet continues to improve due to strong contribution from core module business as well as high margin project sales. Cash in the Q4 increased from $341mn in Q2 to $408mn which helped to improve the net debt/cap ratio which declined from 47.7% in Q2 36.1% in Q3. We believe, over the next year, CSIQ's balance sheet could continue to strengthen as we estimate ~$240mn of cash could be raised from the sale of the 387MW Canadian project backlog
HOUSTON, Nov. 13, 2014 /PRNewswire/ -- Baker Hughes Incorporated (BHI) today confirmed that it has engaged in preliminary discussions with Halliburton Company regarding a potential business combination transaction. These discussions may or may not lead to any transaction. Baker Hughes does not intend to comment further on market speculation or disclose any developments unless and until it otherwise deems further disclosure is appropriate or required.